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ABSTRACT 
 
Comparable hematologic and nutritional outcomes of proximal 
gastrectomy with double-tract reconstruction compared with total 
gastrectomy for early gastric cancer in the upper stomach 
 
Minah Cho 
 
Department of Medicine 
The Graduate School, Yonsei University  
 
(Directed by Professor Woo Jin Hyung) 
 
 
Potential benefits of proximal gastrectomy in terms of hematologic and 
nutritional outcomes over total gastrectomy have been theoretically suggested 
in several studies. However, no proven evidences for the hematological and 
nutritional outcomes have been demonstrated. Thus, we compared 
hematologic and nutritional outcomes after proximal gastrectomy with 
double-tract reconstruction with those after total gastrectomy. 
From September 2014 to December 2015, there were 80 patients underwent 
minimally invasive surgery, proximal gastrectomy or total gastrectomy, for 
stage I gastric cancer. We divided patients into two groups: proximal 
gastrectomy group, 38 patients underwent proximal gastrectomy with double-
tract reconstruction and total gastrectomy group, 42 patients underwent total 
gastrectomy. We retrospectively analyzed clinicopathologic, hematologic, and 
nutritional features. 
We found no significant differences in hematologic outcomes. Change of 
hemoglobin level and cumulative incidence of iron deficiency anemia between 
the two groups were similar (p = 0.250 and 0.971, respectively) with a median 
follow up period of 24 months (range 18 – 30 months) after surgery. 
Cumulative incidence of vitamin B12 deficiency did not significantly differ 
between the proximal gastrectomy group and the total gastrectomy group (p = 
0.087). There was no significant difference in the patients’ BMI changes from 
２ 
 
baseline between the proximal gastrectomy group and the total gastrectomy 
group (p = 0.591). In the nutritional features, there were no statistically 
significant differences. 
This study showed that proximal gastrectomy with double-tract reconstruction 
and total gastrectomy have no statistically different outcomes in terms of 
hematologic and nutritional aspect, especially in emergence of iron deficiency 
and vitamin B12 deficiency anemia. In conclusion, for patients with gastric 
cancer located in upper third of the stomach, proximal gastrectomy with 
double-tract reconstruction can be considered as an alternative option with 
comparable outcomes of total gastrectomy, if oncological safety is assured. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
---------------------------------------------------------------------------------------- 
Key words : proximal gastrectomy, double-tract reconstruction, total 
gastrectomy, hematologic, nutritional, iron deficiency anemia, vitamin 
B12 deficiency  
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I. INTRODUCTION 
 
In recent years adenocarcinoma in the proximal stomach is increasing, although 
the overall incidence of gastric cancer has decreased
1-3
. In Korea and Japan, 
the proportion of early gastric cancer has been increased due to mass 
screening program
3-5
. These tendencies lead increasing incidence of proximal 
early gastric cancer especially in East Asian countries. 
Although the current standard treatment for proximal early gastric cancer is 
total gastrectomy, proximal gastrectomy has been applied as a function-
preserving surgery to improve quality of life
6-9
. It saves gastric reservoir and 
parietal cells by preserving distal stomach
10
. This reduction of the extent of 
gastrectomy might improve oral intake after surgery through remnant gastric 
reservoir. Preservation of intrinsic factor secretion from the parietal cells in 
the distal remnant stomach maintains vitamin B12 absorption. Furthermore, 
proximal gastrectomy provides route of iron absorption by allowing food 
passage to the duodenum
11,12
. Therefore, proximal gastrectomy is expected to 
be theoretically beneficial for nutrients absorption and oral intake, in terms of 
hematologic, nutritional and metabolic aspects
9,13-16
.  
Despite above theoretical advantages, however, surgeons are reluctant to 
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perform proximal gastrectomy due to reflux esophagitis after 
esophagogastrostomy or gastric stasis after jejunal interposition
17,18
. To 
overcome these drawbacks, double-tract reconstruction after proximal 
gastrectomy was developed
19
 and performed frequently
3,20-23
. As surgical 
feasibility of double-tract reconstruction after proximal gastrectomy with 
resolution of those drawbacks have been demonstrated
21,24
, this new 
reconstruction method becomes major reconstruction method after proximal 
gastrectomy in Korea
3
. However, there are only few studies evaluating 
hematologic and nutritional outcomes of proximal gastrectomy with double-
tract reconstruction compared with total gastrectomy
25
. Therefore we aimed to 
assess effects of proximal gastrectomy with double-tract reconstruction on 
hematologic and nutritional outcomes by comparing with those of total 
gastrectomy. 
 
 
II. MATERIALS AND METHODS 
 
1. Patients 
We performed proximal gastrectomy with double-tract reconstruction from 
September 2014 for proximal early gastric cancer. We retrospectively 
reviewed the prospectively collected database of patients with gastric cancer 
who underwent curative gastrectomy from September 2014 to December 2015, 
at the department of Surgery, Severance Hospital, Yonsei University College 
of Medicine, Seoul, Korea. This study was approved by the institutional 
review board of Severance Hospital, Yonsei University Health System (4-
2016-0427). 
There were a total of 108 consecutive patients who underwent minimally 
invasive (laparoscopic or robotic) proximal or total gastrectomy for stage I 
gastric cancer. Among these patients, we excluded 28 patients due to 
preoperative vitamin B12 deficiency (n = 1), insufficient evaluation of vitamin 
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B12 or iron profile (n = 25), and follow-up loss (n = 2). Finally 80 patients 
were included in this study: 38 patients of proximal gastrectomy group who 
underwent minimally invasive proximal gastrectomy with double-tract 
reconstruction and 42 patients of total gastrectomy group who underwent 
minimally invasive total gastrectomy with Roux-en-Y esophagojejunostomy. 
The indication for proximal gastrectomy was patients who were diagnosed as 
clinical early gastric cancer without evidence of lymph node metastasis and 
located in the upper-third of the stomach. If there was any deformities or ulcer 
scar on distal stomach or duodenum, the proximal gastrectomy was not 
indicated. 
 
2. Surgical procedure 
A. Robotic/Laparoscopic total gastrectomy: The detailed procedures of 
minimally invasive total gastrectomies in our institution were described 
previously.
26,27
 For reconstruction, the abdominal esophagus was fully 
mobilized and rotated 90-degree in counter-clockwise direction. After 
transection of esophagus using an articulating 45 mm linear stapler with blue 
cartridge, proximal jejunum was brought up to the esophageal stump then 
posterior wall of esophagus and anti-mesenteric side of jejunum was 
anastomosed intracorporeally using overlap method with linear stapler. The 
common entry hole was closed using stapler but hand-sewn closure also used 
occasionally when anastomosis level is high. Then jejunal loop 2–3 cm 
proximal to the anastomosis was divided without mesenteric division, and it 
was anastomosed to the Roux-limb at 50 cm below the esophagojejunostomy. 
All of the anastomoses were performed intracorporeally using a 45 mm linear 
stapler with white cartridge (Figure 1a). 
 
B. Robotic/Laparoscopic proximal gastrectomy with double-tract reconstruction: 
Detailed procedure of laparoscopic proximal gastrectomy with double-tract 
reconstruction was also described in detail, previously
23
. Robotic procedures 
were not different from laparoscopic procedures except for devices used in 
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peritoneal cavity. The stomach was transected above the gastric angle using a 
45 mm linear stapler with blue cartridges. Anastomoses including the 
esophagojejunostomy, jejunogastrostomy, and jejunojejunostomy were 
performed for double-tract reconstruction: the esophagojejunostomy was 
performed in same manner as in minimally invasive total gastrectomy, the 
jejunogastrostomy was made with blue cartridges at 15 cm below the 
esophagojejunostomy, and jejunojejunostomy was also made with white 
cartridges at 20 cm below the jejunogastrostomy (Figure 1b). 
a)  b)  
Figure 1. Schema of reconstruction. a) Total gastrectomy with Roux-en-Y esophago-
jejunostomy. b) Proximal gastrectomy with double-tract reconstruction. 
 
3. Data collection 
Patients’ demographics including age and gender, pathologic characteristics, 
operative data, clinical and surgical outcomes were collected. Patients’ 
physical status with comorbidities was assessed by the American Society of 
Anesthesiologists Physical Status classification system
28
. Postoperative 
complications were graded by Clavien-Dindo classification of surgical 
complications
29
. We defined complications We classified the fever above 
38.3℃, antipyretics or diuretics use, and correction of electrolyte imbalance as 
a grade I complication and chyle leakage, antibiotics use, hepatotonic agent 
use, medication for pancreatitis, correction of hypoalbuminemia, correction of 
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iron deficiency, and transfusion as a grade II complication. Grade III or higher 
complications were classified as major complications. Every patient’s 
progress was reviewed weekly by surgeons and all complications were 
double-checked and recorded. Pathologic data was collected based on the 7
th
 
edition of the American Joint Committee on Cancer staging system
30
 and 
histologic data was based on the Lauren classification
31
. 
 
4. Hematologic and nutritional outcome measures 
The hematological parameters including hemoglobin, hematocrit, and iron 
profile (serum iron, ferritin, transferrin, transferrin saturation, and total iron-
binding capacity (TIBC)) were measured. The serum ferritin levels were 
measured by a competitive immunoassay using direct chemiluminescence 
(ADVIA Centaur; Bayer Diagnostics, Tarrytown, NY) and serum transferrin 
levels were measured using a nephelometer (Dade Behring, Siemens 
Helathcare Diagnostics, Liederbach, Germany). Transferrin saturation was 
calculated as the ratio of the serum iron level to TIBC multiplied by 100. 
Anemia was defined by hemoglobin <13 g/dL in men or <12 g/dL in women 
according to the World Health Organization criteria
32
 and iron deficiency was 
defined by serum ferritin level <30 ng/mL
33,34
. The serum vitamin B12 level 
was measured using an electrochemiluminescence immunoassay kit (Roche 
DiagnosticsGmbH, Mannheim, Germany) and vitamin B12 deficiency was 
defined as the serum level lower than 200 pg/mL
10
. For evaluation of 
nutritional features, neutrophil count, total lymphocyte count, serum protein 
and albumin, cholesterol levels were also measured. 
 
5. Follow-up 
We followed up all patients every 3 months for one year after the surgery, then 
every 6 months. We checked patients’ weight at every visit and evaluated 
blood test for hematologic and nutritional features. We examined abdomino-
pelvic CT scan every 6 months for initial two years then yearly after. We 
performed upper endoscopy every year. We followed up all patients with the 
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median duration of 24 months (range 18 – 30 months) in both groups. 
 
6. Statistical analysis 
The statistical analysis was performed with the IBM SPSS statistics for 
Windows, Version 23.0 program (Armonk, NY: IBM Corp.). Independent 
variables were compared by using the Chi-square test for categorical variables 
and the Mann-Whitney U test or the Kruskal-Wallis test for continuous 
variables. Cumulative occurrence of anemia and deficiency of vitamin B12 or 
iron was analyzed using the Kaplan-Meier method with the log-rank test. For 
the analysis of changes of continuous variables between two groups, mixed 
model analysis with post-hoc test was performed. A p value <0.05 was 
considered to be statistically significant. 
 
 
III. RESULTS 
 
1. Patients’ characteristics and Surgical outcomes 
There was no statistically significant difference in demographics (Table 1). 
Operation time, estimated blood loss, and length of hospital stay were also 
comparable between two groups (Table 2).  
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Table 1. Patients’ characteristics 
 
Proximal 
gastrectomy 
(n = 38) 
Total gastrectomy 
(n = 42) 
p value 
Gender   0.256 
   Male 32 (84.2%) 31 (73.8%)  
   Female 6 (15.8%) 11 (26.2%)  
Age (years) 55.8 ± 11.6 59.3 ± 11.8 0.184 
ASA-PS classification
1
   0.422 
   1 5 (13.2%) 9 (21.4%)  
   2 27 (71.1%) 24 (57.1%)  
   3 6 (15.8%) 9 (21.4%)  
Weight (kg) 69.1 ± 12.2 66.1 ± 12.6 0.289 
BMI (kg/m
2
)
2
 24.2 ± 3.1 23.5 ± 3.0 0.316 
No. comorbidities   0.647 
   0 18 (47.4%) 21 (50.0%)  
   1 18 (47.4%) 16 (38.1%)  
   2 1 (2.6%) 4 (9.5%)  
   3 1 (2.6%) 1 (2.4%)  
Comorbidity
2
    
   Hypertension 12 (31.6%) 11 (26.2%) 0.595 
   Cardiac 0 (0.0%) 1 (2.4%) >0.999 
   Diabetes 4 (10.5%) 5 (11.9%) >0.999 
   Hepatic 1 (2.6%) 0 (0.0%) 0.475 
   Cerebrovascular 2 (5.3%) 1 (2.4%) 0.602 
   Old tuberculosis 3 (7.9%) 6 (14.3%) 0.487 
   Asthma 0 (0.0%) 1 (2.4%) >0.999 
1
 American Society of Anesthesiologists Physical Status (ASA-PS) classification system 
2
 Body mass index 
3
 Includes all comorbidities in patients with multiple diseases 
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Table 2. Surgical outcomes 
 
Proximal 
gastrectomy 
(n = 38) 
Total 
gastrectomy 
(n = 42) 
p value 
Method   0.133 
   Laparoscopic 27 (71.1%) 23 (54.8%)  
   Robotic 11 (28.9%) 19 (45.2%)  
Lymph node dissection   0.001 
   D1+ 38 (100%) 31 (73.8%)  
   D2 0 (0.0%) 11 (26.2%)  
Combined resection    
   Gall bladder 1 (2.6%) 2 (4.8%) >0.999 
   Adrenal 1 (2.6%) 0 (0.0%) 0.475 
Operation time (min) 217.7 ± 53.0 226.9 ± 66.2 0.498 
Estimated Blood Loss (mL) 100.2 ± 92.0 118.8 ± 157.2 0.528 
Intraoperative transfusion   0.495 
   No 38 (100%) 40 (95.2%)  
   Yes 0 (0.0%) 2 (4.8%)  
Length of hospital Stay (day) 8.18 ± 5.72 8.44 ± 9.55 0.882 
 
In terms of postoperative morbidity (Table 3), 17 complications occurred in 16 
patients underwent proximal gastrectomy and 28 complications occurred in 26 
patients underwent total gastrectomy. Although overall complication rate was 
lower in proximal gastrectomy group (42.1%) than in total gastrectomy group 
(61.9%), there was no statistical significance (p = 0.077). In the patients with 
complication, rate of major complications above grade III was also lower in 
proximal gastrectomy group (12.5%) than in total gastrectomy group (38.5%, 
p =0.102, Table 4), however it was not statistically different. 
Proximal gastrectomy group had lower incidence of anastomosis-related 
complications compared with total gastrectomy group, although it was not 
statistically significant (2.6% vs. 14.3%, p = 0.112). One patient in proximal 
gastrectomy group (2.6%) and four paitents in total gastrectomy group (9.5%) 
suffered from anastomotic leakage of esophagojejunostomy (p = 0.362). 
Among them, two patients in total gastrectomy group underwent re-operation 
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Table 3. Postoperative morbidity (within 30 postoperative days) 
 
Proximal 
gastrectomy 
(n = 38) 
Total 
gastrectomy 
(n = 42) 
p value 
Complication   0.077 
   No 22 (57.9%) 16 (38.1%)  
   Yes 16 (42.1%) 26 (61.9%)  
Intra-abdominal complication    
   Fluid collection/abscess 3 (7.9%) 0 (0.0%) 0.103 
   Anastomotic leakage 1 (2.6%) 4 (9.5%) 0.362 
   Anastomotic stenosis 0 (0.0%) 2 (4.8%) 0.495 
   Duodenal stump leakage 0 (0.0%) 1 (2.4%) >0.999 
   Cholecystitis 1 (2.6%) 0 (0.0%) 0.475 
   Pancreatitis 2 (5.2%) 1 (2.4%) 0.602 
   Chylous ascites 2 (5.2%) 0 (0.0%) 0.222 
   Profuse drainage 1 (2.6%) 0 (0.0%) 0.475 
Wound complication 1 (2.6%) 4 (9.5%) 0.362 
Medical complications    
   Respiratory 1 (2.6%) 2 (4.8%) >0.999 
   Cardiovascular 0 (0.0%) 1 (2.4%) >0.999 
   Urinary 1 (2.6%) 3 (7.1%) 0.617 
 
 
Table 4. Severity of complications according to Clavien-Dindo classification 
 
Proximal 
gastrectomy 
(n = 16) 
Total 
gastrectomy 
(n = 26) 
p value 
Clavien-Dindo Grade   0.102 
   Grade I 4 (25.0%) 9 (34.6%)  
   Grade II 10 (62.5%) 7 (26.9%)  
   Grade III 2 (12.5%) 9 (34.6%)  
   Grade IV 0 (0.0%) 1 (3.8%)  
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under the general anesthesia for surgical correction of anastomotic leakage, 
others were treated with procedures under the local anesthesia such as 
endoscopic procedures or percutaneous drainage catheter insertion (Table 5). 
Only in total gastrectomy group, esophagojejunostomy stenosis in two 
patients (4.8%, p = 0.495) and duodenal stump leakage in one patient (2.4%, p 
>0.999) occurred. On the other hand, patients with intra-abdominal fluid 
collection were only in proximal gastrectomy group (7.9%, p = 0.103) and 
managed with conservative method. 
One patient in proximal gastrectomy group complained of fever and chilling on 
15
th
 postoperative day was diagnosed with cholecystitis due to gallstone in the 
distal common bile duct and finally underwent cholecystectomy with 
intraoperative cholangiogram. Another patient who had past history of 
percutaneous coronary stent insertion in total gastrectomy group showed 
abnormal demonstration on electrocardiogram and elevated cardiac enzyme 
after gastric surgery. He was diagnosed with Non-ST elevation myocardial 
infarction and then underwent coronary angiography with stent insertion. The 
patients with other complications successfully treated with conservative 
management and there were no differences between two groups. There was no 
mortality in both groups. 
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Table 5. Types and management of grade III or higher postoperative morbidity 
Grade
1
 Complication Group
2
 Management 
IIIa Anastomotic leakage PG PCD
3
, Endoscopic stent 
  TG Endoscopic stent 
  TG Endoscopic stent, E-VAC
4
 
 Anastomotic stenosis TG Endoscopic dilatation 
  TG Endoscopic dilatation 
 Duodenal stump leakage TG PCD 
 Pleural effusion TG PCD 
  TG PCD 
 Non-STEMI TG Coronary stent insertion 
IIIb Anastomotic leakage TG Re-operation 
 Cholecystitis due to CBD stone PG Cholecystectomy 
IV Anastomotic leakage TG Re-operation, ICU
5
 admission 
1
 according to Clavien-Dindo classification 
2
 PG: proximal gastrectomy with double-tract reconstruction, 
 TG: total gastrectomy with Roux-en-Y esophagojejunostomy 
3
 PCD: Percutaneous catheter drainage 
4
 E-VAC: Endoscopic vaccum-assisted closure system 
5
 ICU: Intensive care unit 
 
 
In histopathologic characteristics (Table 6), tumor size, distal margin, and 
number of retrieved lymph nodes (p = 0.034, <0.001, and 0.005, respectively) 
showed significant difference as expected due to different extent of resection 
and lymph node dissection. The proximal gastrectomy group tended to have 
lower pathologic stage of tumor compared with total gastrectomy group (p = 
0.047), while T stage and N stage did not differ between two groups (p = 
0.112 and >0.999, respectively). 
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Table 6. Histopathologic characteristics 
 
Proximal 
gastrectomy 
(n = 38) 
Total 
gastrectomy 
(n = 42) 
P value 
Tumor location (Tubular) 0.067 
EG junction 2 (5.3%) 1 (2.4%)  
Cardia 5 (13.2%) 10 (23.8%)  
Fundus 0 (0.0%) 0 (0.0%)  
Upper body 24 (63.2%) 15 (35.7%)  
Mid body 7 (18.4%) 11 (26.2%)  
Lower body 0 (0.0%) 2 (4.8%)  
Tumor size (mm) 21.4 ± 17.1 32.5 ± 27.1 0.034 
Proximal margin (mm) 28.0 ± 22.8 37.6 ± 34.2 0.143 
Distal margin (mm) 62.3 ± 26.0 130.7 ± 45.2 <0.001 
Histology (Lauren)   >0.999 
   Intestinal 19 (51.4%) 21 (50.0%)  
   Diffuse 17 (45.9%) 18 (42.9%)  
   Mixed 0 (0.0%) 1 (2.4%)  
   Indeterminate 1 (2.7%) 2 (4.8%)  
T stage   0.112 
   T1a (m) 17 (44.7%) 17 (40.5%)  
   T1b (sm) 20 (52.6%) 17 (40.5%)  
   T2 (mp) 1 (2.6%) 8 (19.0%)  
N stage   >0.999 
   N0 37 (97.4%) 40 (95.2%)  
   N1 1 (2.6%) 2 (4.8%)  
Stage   0.045 
   Stage IA 36 (94.7%) 32 (76.2%)  
   Stage IB 2 (5.3%) 10 (23.8%)  
Retrieved lymph nodes 43.9 ± 15.7 56.2 ± 21.7 0.005 
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2. Hematologic Outcomes 
The concentration of hemoglobin, ferritin, TIBC, and transferrin did not 
statistically differ between two groups (p = 0.250, 0.602, 0.226, and 0.168, 
respectively), whereas serum iron and transferrin saturation showed 
significant difference between two groups (p = 0.007 and 0.026, respectively, 
Figure 2a-f). The cumulative incidence of anemia was lower after proximal 
gastrectomy than total gastrectomy, however, the difference was not 
statistically significant (p = 0.690, Figure 2g). Patients in both groups had 
almost same cumulative incidence of iron deficiency anemia after 18 months  
(p = 0.971, Figure 2h). 
 
 
 
a)  b)  
c)  d)  
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e)  f)  
g) h)  
 
Figure 2. Changes in hematologic parameters. Level of a) hemoglobin, b) ferritin,    
c) iron, d) total iron-binding capacity, e) transferrin, and f) transferrin saturation. 
Cumulative incidence of g) anemia and h) iron deficiency anemia. PG proximal 
gastrectomy with double-tract reconstruction, TG total gastrectomy with Roux-en-Y 
esophagojejunostomy, TIBC Total iron-binding capacity. 
 
 
3. Vitamin B12 metabolism 
For accurate analysis, we excluded patients who supplemented with vitamin 
B12 from the analysis at the time of supplementation and thereafter. In both 
groups, levels of vitamin B12 were over 600 pg/mL preoperatively. However, 
it decreased markedly below 300 pg/mL at 3 months after surgery and 
converged to 200 pg/mL until 9 months after surgery. At 12 months after 
surgery, there was no available value in total gastrectomy group because all of 
the patients who underwent total gastrectomy supplemented with vitamin B12 
after 18 months. The mean changes of vitamin B12 level did not differ 
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between two groups (p = 0.095, Figure 3a).  
Figure 3b shows cumulative incidence of vitamin B12 deficiency after surgery. 
Proximal gastrectomy group had lower cumulative incidence of vitamin B12 
deficiency compared with total gastrectomy group: approximately 85% of 
patients in proximal gastrectomy group suffered from vitamin B12 deficiency 
at 24 months after surgery. On the contrary, although the difference was not 
statistically significant, 100 % of the patients in total gastrectomy group 
experienced vitamin B12 deficiency within 21 months after surgery (p = 
0.087).  
 
 a) b)  
Figure 3. Comparison of vitamin B12 metabolism between PG and TG. a) Changes in 
vitamin B12 level without supplementation. b) Cumulative incidence of vitamin B12 
deficiency. PG proximal gastrectomy with double-tract reconstruction, TG total 
gastrectomy with Roux-en-Y esophagojejunostomy. 
 
 
4. Weight and nutritional parameters 
Mean changes in BMI from baseline are shown in Figure 4. In both groups, 
BMI decreased more than 2.5 kg/m
2
 from baseline until 12 months after 
surgery. After that, BMI in proximal gastrectomy group tended to recover 
while those in total gastrectomy group remained at the plateau. However, its 
difference was not statistically significant between two groups (p = 0.591). 
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Figure 4. Mean changes in body mass index from baseline. PG proximal gastrectomy 
with double-tract reconstruction, TG total gastrectomy with Roux-en-Y esophago-
jejunostomy 
 
In nutritional aspect, the proximal gastrectomy group showed similar level of 
total protein, albumin and similar total lymphocyte count compared to the 
total gastrectomy group (p = 0.678, 0.743, 0.938 and 0.144, respectively, 
Figure 5). 
 
a)  b)  
c)  d)  
Figure 5. Changes in nutritional parameters. Level of a) total protein, b) albumin,    
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c) cholesterol. d) Total lymphocyte count. PG proximal gastrectomy with double-tract 
reconstruction, TG total gastrectomy with Roux-en-Y esophagojejunostomy. 
 
 
IV. DISCUSSION 
In our study, minimally invasive proximal gastrectomy with double-tract 
reconstruction had comparable outcomes to minimally invasive total 
gastrectomy with Roux-en-Y esophagojejunostomy in terms of surgical, 
hematologic and nutritional aspects. Analyses of the hematologic parameters, 
including hemoglobin, ferritin, and transferrin saturation also showed that 
postoperative levels did not differ between two groups. Although the 
cumulative incidence of anemia was lower in proximal gastrectomy group 
than total gastrectomy group, the difference was not statistically significant. 
Furthermore, two groups showed similar cumulative incidence of iron 
deficiency anemia. The nutritional parameters showed comparable levels in 
both groups. 
Proximal gastrectomy followed by various reconstruction methods except 
double-tract reconstruction completely preserves food passage into the 
duodenum, whereby it have been reported to have better outcome for iron 
metabolism compared to total gastrectomy
13-16,35-38
. On the other hand, double-
tract reconstruction only preserves duodenal food passage partially because it 
literally has two ways of food passage. Nonetheless, this reconstruction is also 
expected to be beneficial on iron metabolism. Although most studies have 
analyzed mean level of hematologic parameters, it have showed favorable or 
comparable outcomes on iron metabolism following double-tract 
reconstruction for proximal gastrectomy compared with total gastrectomy
12,22
. 
In the present study, the mean levels of hemoglobin and ferritin were higher in 
proximal gastrectomy group compared with those in total gastrectomy group 
as expected. However, the values in both groups still remained within the 
normal range and difference was not statistically significant. Moreover, the 
cumulative incidence of anemia and iron deficiency anemia were not different 
２０ 
 
between the two groups. Partial preservation of duodenal food passage by 
diversion in double-tract reconstruction makes amount of iron absorption 
much reduced. While accurate proportion of food passage through the 
duodenum in proximal gastrectomy with double-tract reconstruction has never 
been reported, one study described that contrast material passes into the 
duodenum and 60% of ingested food was found in remnant stomach after 
double-tract reconstruction
12
. This partial passage of ingested food into the 
duodenum through jejunogastrostomy would be insufficient to prevent iron 
deficiency. 
Iron deficiency might be due to not only reconstruction method but gastrectomy 
itself, since decreased oral intake caused by reduction of volume of the 
stomach after gastrectomy affects decreased iron intake. Similar phenomenon 
was also observed even after distal subtotal gastrectomy with 
gastroduodenostomy (Billroth I anastomosis) which completely preserves 
food passage to the duodenum. Iron deficiency occurred in more than half of 
the patients after distal subtotal gastrectomy with gastroduodenostomy 
(Billroth I anastomosis) in 3 years after gastrectomy
11
. Preservation of distal 
stomach after proximal gastrectomy would not be sufficient to prevent iron 
deficiency. In addition, decreased chief cell mass on stomach and vagotomy 
decreases gastric acidity resulted in decreased efficacy of iron absorption. 
Therefore, iron deficiency after proximal gastrectomy with double-tract 
reconstruction would be inevitable. 
With regard to vitamin B12 metabolism, distal stomach preservation in 
proximal gastrectomy have been reported to have beneficial effect
12,22,35
. Most 
studies regarding proximal gastrectomy with double-tract reconstruction 
reported just mean level of vitamin B12 after surgery without exact incidence 
of vitamin B12 deficiency. When we compared cumulative incidence of 
vitamin B12 deficiency after proximal gastrectomy with double-tract 
reconstruction, it was similar to that after total gastrectomy. 
The parietal cell is most important factor for vitamin B12 metabolism because 
absorption of vitamin B12 is mediated by intrinsic factor released from gastric 
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parietal cell. Since gastric parietal cells mainly located in anatomical body of 
the stomach
39
, the patient who underwent proximal gastrectomy might have 
small parietal cell volume due to paucity of parietal cell in gastric antrum and 
pylorus. The parietal cell volume after gastrectomy could be related to the 
volume of gastric remnant. In addition, volume of parietal cell would be 
influenced by pathologic change of remnant gastric mucosa after proximal 
gastrectomy with double-tract reconstruction such as atrophic gastritis or 
intestinal metaplasia
40,41
. Therefore, vitamin B12 deficiency after proximal 
gastrectomy with double-tract reconstruction would also be inevitable. 
In our institution, as mentioned above, stomach was transected above the angle, 
and only two or three branches of right gastric and gastroepiploic arteries were 
preserved. That means volume of the remnant stomach is about half of entire 
stomach. This small volume of remnant stomach might have affected our 
results. Compared with a study reported superior clinical and nutritional 
outcomes after proximal gastrectomy with double-tract reconstruction 
compared with total gastrectomy
22
, distal resection margin in proximal 
gastrectomy group of our study (6.2 cm) was much greater than that study (2.8 
cm). While the mean value of tumor size and proximal resection margin are 
similar, the volume of the gastric remnant in our study is smaller than theirs. 
We may suppose that disparities in the volume of the gastric remnant make 
different hematologic and nutritional outcomes. 
Moreover, the remnant gastric volume is also a factor affecting recovery of the 
amount of food intake and gastrointestinal symptoms after surgery. Thus, 
small remnant gastric volume could make these similar outcomes of proximal 
gastrectomy compared with total gastrectomy. With regard to remnant volume 
of the stomach, patients with a larger remnant stomach (1/2 resected group) 
showed higher postoperative/preoperative body weight ratios compared to 
those with small remnant stomach (2/3 resected group) and with no remnant 
stomach (total gastrectomy group)
25
. In this study, the changes in BMI from 
baseline were not significantly different between proximal gastrectomy with 
double-tract reconstruction group and total gastrectomy group. Considering 
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that food intake has a significant impact on body weight, relatively small 
volume of remnant stomach as a reservoir could cause insufficient food intake. 
However, according to a nationwide questionnaire survey in Japan, about 30% 
of institutions answered that they preserve less than half of entire stomach or 
decide the volume of remnant depending on case during performing proximal 
gastrectomy
20
. Thus, further research to indicate the appropriate volume of the 
gastric remnant is required. 
Rate of anastomosis-related complication was lower in proximal gastrectomy 
group compared to total gastrectomy group, although it was not significantly 
different between two groups. It might be postulated by reduced tension to the 
esophagojejunostomy by jejunogastrostomy as supporting structure for Roux-
limb, or by deconcentrating of food passage pressure to the alternative way of 
gastric remnant via jejunogastrostomy. However, it is unclear whether the 
proximal gastrectomy with double-tract reconstruction may reduce 
anastomosis-related complications. 
Since we have relatively small number of included patients, it was difficult to 
show statistical differences. However, our study population was relatively 
larger among studies comparing proximal gastrectomy with double-tract 
reconstruction to total gastrectomy. Short duration of follow-up is another 
limitation. We could not evaluate oncologic outcomes such as survival rate or 
recurrences. Therefore, for further understanding of proximal gastrectomy, 
well-organized study of large scale in current indication is needed. A 
multicenter prospective randomized controlled trial of comparing laparoscopic 
proximal gastrectomy with double-tract reconstruction with total gastrectomy 
for upper third early gastric cancer (KLASS-05, NCT02892643)
42
 is in 
progress in Korea. We expect confirmative results regarding efficacy of 
proximal gastrectomy with double-tract reconstruction on clinical, surgical 
and functional outcomes from KLASS-05 trial. 
Despite these limitations, our results showed the similar short-term outcomes of 
proximal gastrectomy with double-tract reconstruction compared with total 
gastrectomy. Additional research of vitamin B12 metabolism associated with 
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parietal cell distribution in remnant stomach and iron metabolism associated 
with duodenal food passage would be necessary to further understand the 
consequences after proximal gastrectomy with double-tract reconstruction. 
 
 
V. CONCLUSION 
 
Proximal gastrectomy with double-tract reconstruction and total gastrectomy 
has similar outcomes in hematolotic and nutritional aspects, especially in 
vitamin B12 deficiency and iron-deficiency anemia. For patients with gastric 
cancer located in upper third of the stomach, proximal gastrectomy with 
double-tract reconstruction can be considered as an alternative option with 
comparable outcomes of total gastrectomy, if oncological safety is assured. 
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